0

Purchase Short-Term Access

Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Multicenter Clinical Trial
Robert M. Jasmer, MD; Jussi J. Saukkonen, MD; Henry M. Blumberg, MD; Charles L. Daley, MD; John Bernardo, MD; Eric Vittinghoff, PhD; Mark D. King, MD; L. Masae Kawamura, MD; Philip C. Hopewell, MD; Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection (SCRIPT) Study Investigators*
Annals of Internal Medicine 2002;137:640-647. doi:10.7326/0003-4819-137-8-200210150-00007

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)